Soleno Therapeutics (SLNO) Profit After Tax: 2013-2024
Historic Profit After Tax for Soleno Therapeutics (SLNO) over the last 9 years, with Dec 2024 value amounting to -$175.9 million.
- Soleno Therapeutics' Profit After Tax fell 81.50% to -$4.7 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$15.4 million, marking a year-over-year decrease of 27.52%. This contributed to the annual value of -$175.9 million for FY2024, which is 351.16% down from last year.
- Latest data reveals that Soleno Therapeutics reported Profit After Tax of -$175.9 million as of FY2024, which was down 351.16% from -$39.0 million recorded in FY2023.
- Over the past 5 years, Soleno Therapeutics' Profit After Tax peaked at -$24.1 million during FY2022, and registered a low of -$175.9 million during FY2024.
- Moreover, its 3-year median value for Profit After Tax was -$39.0 million (2023), whereas its average is -$79.7 million.
- Data for Soleno Therapeutics' Profit After Tax shows a maximum YoY slumped of 351.16% (in 2024) over the last 5 years.
- Soleno Therapeutics' Profit After Tax (Yearly) stood at -$24.1 million in 2022, then slumped by 62.00% to -$39.0 million in 2023, then tumbled by 351.16% to -$175.9 million in 2024.